
Summary
Neurocrine Group Limited is a rare disease-focused pharmaceutical company and the former Diurnal Group, operating as Neurocrine Biosciences’ European rare commercial business.
Deals Overview
All rights reserved. Copyright © 2026 Datasite
Senior Management
Richard Bungay
Interim CEO
Kyle Gano
Chief Business Development and Strategy Officer
Anders Härfstrand
Non-Executive Chairman
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy